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Objectives. The purposes of this study were to determine the
growth pattern of the pulmonary valve (PV) annulus and right
heart structures in patients with critical and severe pulmonary
stenosis (PS) after balloon dilation, and to determine any mor-
phometric or hemodynamic differences between cyanotic infants
with critical PS and asymptomatic infants with severe PS that may
account for their varied clinical presentations.
Background. Growth of the PV annulus and right heart struc-
tures in patients with critical PS after balloon valvuloplasty has
not clearly been defined. In addition, the anatomic and hemody-
namic factors that determine whether an infant with severe PS
will present with cyanosis or without symptoms are not well
understood.
Methods. Measurements of the PV annulus, tricuspid valve
(TV) annulus and main, right and left pulmonary arteries were
obtained from initial and follow-up echocardiograms, and Z
values were calculated. Hemodynamic data and balloon pulmo-
nary valvuloplasty techniques were reviewed. Right ventricular
(RV) volumes were measured from angiograms.
Results. Fourteen patients with critical PS (mean [6SD] age
0.21 6 0.37 months) and 20 patients with severe PS (mean age
2.6 6 2.9 months) were evaluated at presentation and at 32 6 33
and 42 6 32 months of follow-up, respectively. Balloon pulmonary
valvuloplasty was successful in 64% of patients with critical PS
and in 90% of patients with severe PS. The PV, TV and pulmonary
arteries increased in size after balloon pulmonary valvuloplasty in
both groups at a rate that paralleled or exceeded the rate of
somatic growth. The initial TV diameter and RV volume were
smaller in patients with critical PS than in those with severe PS
(p < 0.05 and p < 0.0008, respectively).
Conclusions. After balloon pulmonary valvuloplasty in infants
with critical and severe PS, right heart structures increase in size
at a rate that parallels or exceeds the rate of somatic growth. The
primary morphometric differences between these groups are a
smaller TV diameter and RV volume in infants with critical PS.
This may contribute to increased right to left atrial shunting and
account for the variations in clinical presentation.
(J Am Coll Cardiol 1997;29:1095–101)
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Pulmonary stenosis (PS) accounts for ;8% to 12% of patients
with congenital heart disease and is generally well tolerated
(1–5). Severe PS with right ventricular (RV) pressure greater
than or equal to systemic pressure is uncommon. Infants with
severe PS can be categorized into two distinct groups based on
their clinical presentation: 1) critically ill infants with cyanosis
whose pulmonary blood flow may depend on ductal patency
and require urgent intervention; and 2) asymptomatic infants.
The anatomic and hemodynamic factors that determine the
clinical presentation of infants with severe PS are not well
understood.
Balloon pulmonary valvuloplasty has become the treatment
of choice for patients with PS, including infants with critical
and severe PS (6–8). The success rates of balloon pulmonary
valvuloplasty in infants with critical PS have been reported to
be 55% to 94%; however, restenosis has been reported in 17%
to 36% of these patients (7–14). The pulmonary valve (PV)
annulus and right heart structures have been characterized as
hypoplastic in some patients with critical PS, and growth of
these structures relative to somatic growth after balloon pul-
monary valvuloplasty has been a subject of controversy
(7,14).
The purposes of this study were: 1) to determine the growth
rate of the PV and right heart structures relative to somatic
growth after balloon dilation of the PV; and 2) to determine
any morphometric or hemodynamic differences between in-
fants with critical PS and those with severe PS that may
account for their varied clinical presentations.
Methods
Study patients. The medical records, echocardiograms,
cineangiograms and cardiac catheterization data of all patients
,1 year of age with the diagnosis of PS who presented to the
Texas Children’s Hospital from 1983 to 1994 were reviewed.
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Included in this study were all infants who had: 1) severe PS,
defined as thickened, doming leaflets as seen echocardio-
graphically or angiographically with evidence of anterograde
flow across the PV and a RV to left ventricular (LV) pressure
ratio $1 with an intact ventricular septum documented by
cardiac catheterization; 2) a complete two-dimensional and
Doppler echocardiographic examination before intervention;
and 3) clinical and echocardiographic follow-up data available
for review. Patients were divided into two groups according to
their clinical profile at initial presentation. Group 1 included
infants with critical PS, defined as severe PS in an infant with
cyanosis, arterial oxygen saturation #92% or signs and symp-
toms of low cardiac output at initial presentation. These
infants required prostaglandin E1 infusion or other urgent
intervention. Group 2 included infants with severe PS who
were acyanotic and asymptomatic at initial presentation. Pa-
tients with pulmonary atresia, supravalvar PS and an Ebstein
anomaly were excluded. The presence of associated infundib-
ular stenosis due to hypertrophy was not used as an exclusion
criteria. Clinical and demographic information was obtained
from review of the medical records.
Echocardiography. Initial and follow-up echocardiograms
were performed with several commercially available scanners
with the transducer frequency appropriate for the patient’s
size. Studies were recorded on 1⁄2-in. super-VHS videotape. All
echocardiograms were reviewed, and selected still frames were
identified for subsequent analysis. Measurements were per-
formed off-line with a digitizing tablet (Summagraphic II)
interfaced with a personal computer and a commercially
available software package (Digisonics EchoPro System, ver-
sion 3.30). Measurements were performed on the initial and
follow-up echocardiograms. Each measurement was per-
formed three times and the mean value was used for data
analysis.
The PV annulus was measured in the parasternal short-axis
view as the maximal distance between the hinge points of the
valve leaflets in systole. The main pulmonary artery (PA)
diameter was measured in the parasternal short-axis view in
systole, ;1 cm above the valve annulus. Right and left PA
diameters were measured in the high parasternal and su-
prasternal notch views in systole, just proximal to the first
branch of each vessel. The tricuspid valve (TV) annulus was
measured in the apical four-chamber view as the maximal
distance between the hinge points of the valve leaflets in
diastole. Linear dimensions were indexed to the square root of
body surface area to allow comparison of measurements
between patients of varied size (15). Corresponding Z values
were calculated for the PV annulus, TV annulus and main,
right and left PAs by the formula:
Z 5
Measured value 2 Mean value of normal control
Standard deviation of normal control
.
The normative data are derived from measurements of 140
children without heart disease (unpublished data from Chil-
dren’s Hospital, Boston, Massachusetts).
The maximal instantaneous gradient across the PV was
calculated from the peak spectral Doppler velocity using the
modified Bernoulli equation (16,17). Pulmonary and tricuspid
valve and PV regurgitation was graded as none, trivial, mild,
moderate or severe based on the width of the regurgitant jet at
its origin as seen by color Doppler flow mapping. The atrial
septum was evaluated for the presence of an atrial septal
defect or patent foramen ovale, and the direction of flow
across the atrial communication was examined using pulsed
and color Doppler flow mapping. The presence of a patent
ductus arteriosus and the direction of flow were also noted.
Catheterization. The techniques used for balloon pulmo-
nary valvuloplasty in our institution have been previously de-
scribed in detail (18,19). The following balloon dilation tech-
niques were noted: single- or double-balloon dilation technique
and graduated or nongraduated balloon dilation technique. A
graduated technique was defined as the initial dilation being
performed with a smaller diameter balloon and then progress-
ing to additional inflations with a larger diameter balloon. The
maximal balloon diameters were recorded, and in the cases in
which a double-balloon technique was used, the sum of the
diameters of the simultaneously used balloons was used for
analysis. The maximal balloon to PV annulus ratio was calcu-
lated. The number of inflations and maximal inflation pres-
sures were recorded. The operator and year of procedure were
also noted. Right ventricular end-diastolic and right atrial
pressures were recorded. Right ventricular volumes in systole
and diastole were measured from the initial right ventriculo-
grams using the biplane Simpson method and either a cardio-
marker or catheter size for calibration (Digisonics Inc. 1993,
CathPro, Cath Lab Analysis System). Right ventricular ejec-
tion fraction was calculated as (end-diastolic volume 2 end-
systolic volume)/end-diastolic volume. The RV to PA pressure
gradient and the RV to LV pressure ratio were measured
before and after balloon pulmonary valvuloplasty. In cases in
which the LV was not entered, systemic pressure was used.
Any complications reported in the catheterization record were
noted.
Outcome. Balloon pulmonary valvuloplasty was attempted
as the initial procedure in all patients. Success of balloon
pulmonary valvuloplasty in patients with critical PS was de-
fined by the following criteria: 1) the patient was acyanotic,
allowing for the discontinuation of prostaglandin E1 with no
evidence of ductal flow; 2) the RV systolic pressure remained
#2⁄3 of systemic systolic pressure; and 3) no further interven-
tion was required. The last two criteria defined a successful
procedure in patients with severe PS.
Abbreviations and Acronyms
LV 5 left ventricle, left ventricular
PA 5 pulmonary artery
PS 5 pulmonary stenosis
PV 5 pulmonary valve
RV 5 right ventricle, right ventricular
TV 5 tricuspid valve
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Statistical analysis. Data are expressed as the mean
value 6 SD when appropriate. Measurements of continuous
variables for each group before and after intervention were
compared using a two-tailed paired Student t test. Measure-
ments of continuous variables between groups were compared
using a two-tailed unpaired Student t test. Categoric variables
were compared using the chi-square analysis or Fisher exact
test. The Spearman rank correlation coefficient was used to
compare ordinal variables. Correlation between continuous
variables was calculated using simple linear regression analysis
with the least squares method. A Levenberg Marquette non-
linear curve fit was used to assess growth of right heart
structures as a function of somatic growth. Interobserver
variability was calculated as the difference between the two
observers’ measurements divided by the mean of the two
measurements. A p value ,0.05 was considered significant.
Results
Study patients. Fourteen patients with critical PS and 20
patients with severe PS were included in the study. The
demographic and clinical data of the patients at initial presen-
tation are summarized in Table 1. Patients with critical PS
presented earlier, had a smaller body surface area and had a
lower initial oxygen saturation, and a higher proportion of
these patients required prostaglandin E1 to maintain ductal
patency compared with patients with severe PS. The percent-
age of patients who were intubated and ventilated at the time
of cardiac catheterization was higher in patients with critical
PS than in those with severe PS.
Morphometric analysis. The initial and follow-up morpho-
metric measurements for both groups are shown in Table 2. In
both groups, the average initial Z values of the right heart
structures were smaller than those of normal control subjects,
but remained within normal limits. At follow-up of the critical
PS group, the TV Z value paralleled somatic growth, the PV
annulus Z value increased from 20.05 6 0.8 to 1.0 6 0.9 (p ,
0.003), and the Z values of the main and branch PAs signifi-
cantly increased to ;2 SDs above the mean of normal control
subjects (Fig. 1). Similar growth patterns after balloon pulmo-
nary valvuloplasty were found during follow-up in the severe
PS group. The growth rate of the TV paralleled the rate of
somatic growth, and the growth rate of the PV annulus and
PAs exceeded the rate of somatic growth.
The comparison of the Z values of the initial morphometric
measurements between patients with critical and severe PS
showed the initial TV Z value was slightly but significantly
smaller in patients with critical PS. The RV volume was also
significantly smaller in patients with critical PS compared with
those with severe PS (Table 2). All patients had a tripartite RV
and none of the patients had a RV to coronary artery fistula. A
significant linear correlation was found between the TV diam-
eter and RV volume (r 5 0.4, p , 0.04). The initial Z values for
the PV annulus and main, right and left PAs were not
significantly different between the two groups. At the latest
follow-up, the right and left PAs were both significantly larger
in the group with critical PS compared with the group with
severe PS. There were no significant differences between the
groups for the mean Z values of the TV, PV and main PA.
Table 1. Demographics and Clinical Profile at Initial Presentation
CPS SPS p Value
Age (mo)* 0.21 6 0.37 2.6 6 2.9 , 0.004
Body surface area (m2)* 0.23 6 0.02 0.29 6 0.09 , 0.02
Gender ratio (M/F) 7:7 9:11 0.95
Systemic oxygen saturation (%)* 88 6 9.3 92 6 3.3 , 0.04
PDA 71% 10% , 0.001
PGE1 57% 0 , 0.0001
Intubated at catheterization 64% 25% , 0.05
Doppler gradient (mm Hg)* 74.2 6 31.6 92.6 6 26.8 0.09
ASD/PFO 100% 95% 0.59
F/U duration (mo)* 31.9 6 32.9 42.3 6 32.3 0.44
Data are presented as mean value 6 SD or percent of patients. ASD 5 atrial
septal defect; CPS 5 critical pulmonary stenosis; F/U 5 follow-up; PDA 5
patent ductus arteriosus; PFO 5 patent foramen ovale; PGE1 5 prostaglandin
E1; SPS 5 severe pulmonary stenosis.
Table 2. Morphometric Variables in Infants With Critical and Severe Pulmonary Valve Stenosis





(p value)Initial Follow-Up p Value Initial Follow-Up p Value
TV diameter (cm/BSA0.5) 2.4 6 0.2 2.3 6 0.2 0.21 2.55 6 0.3 2.32 6 0.2 , 0.01 0.07 0.93
TV Z value 0.0 6 0.4 0.2 6 0.6 0.28 0.4 6 0.6 0.2 6 0.6 0.21 , 0.05 0.96
PV diameter (cm/BSA0.5) 1.6 6 0.2 1.9 6 0.2 , 0.006 1.68 6 0.2 1.81 6 0.1 , 0.0002 0.25 0.16
PV Z value 20.5 6 0.8* 1.0 6 0.9 , 0.003 20.2 6 0.8 0.5 6 0.6 , 0.0001 0.23 0.13
MPA diameter (cm/BSA0.5) 1.8 6 0.3 2.2 6 0.4 0.1 1.87 6 0.3 1.95 6 0.2 , 0.01 0.79 0.08
MPA Z value 0.1 6 1.1 2.0 6 1.9 , 0.02 0.3 6 0.9 1.1 6 0.7 , 0.0001 0.54 0.1
RPA diameter (cm/BSA0.5) 1.0 6 0.2 1.4 6 0.3 , 0.003 0.99 6 0.2 1.14 6 0.2 , 0.003 0.97 , 0.01
RPA Z value 20.4 6 0.8 2.1 6 1.6 , 0.002 20.4 6 0.9 0.5 6 1.2 , 0.003 0.82 , 0.01
LPA diameter (cm/BSA0.5) 1.1 6 0.2 1.4 6 0.2 , 0.01 1.0 6 0.2 1.2 6 0.2 , 0.004 0.73 , 0.05
LPA Z value 0.1 6 1.0 2.0 6 1.6 , 0.01 0.0 6 1.0 0.8 6 1.2 , 0.004 0.63 , 0.05
RVEDV (ml/m2) 29.4 6 6.2 NA NA 36.5 6 4.7 NA NA , 0.0008 NA
*p , 0.05 compared with normal control values. Data are presented as mean value 6 SD. BSA 5 body surface area; CPS 5 critical pulmonary stenosis; LPA 5
left pulmonary artery; MPA 5 main pulmonary artery; PS 5 pulmonary stenosis; PV 5 pulmonary valve annulus; RPA 5 right pulmonary artery; RVEDV 5 right
ventricular end-diastolic volume; SPS 5 severe pulmonary stenosis; TV 5 tricuspid valve.
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The initial RV to PA Doppler gradients are shown in Table
1. Among patients with critical PS, 13 had no pulmonary
regurgitation and 1 had mild regurgitation. Among patients
with severe PS, 17 had no pulmonary regurgitation, 1 had
trivial regurgitation and 2 had mild regurgitation (p 5 NS).
Mild or more tricuspid regurgitation was present in 64% of
patients with critical PS compared with 25% of patients with
severe PS (p , 0.03). All of the patients with critical PS and
95% of the patients with severe PS had an atrial level
communication (p 5 NS) (Table 1). The direction of flow was
exclusively or predominantly right to left in patients with
critical PS and exclusively or predominantly left to right in
patients with severe PS. Seventy-one percent of patients with
critical PS and 10% of patients with severe PS had a patent
ductus arteriosus (p , 0.001). The direction of ductal flow was
left to right in all cases.
Interobserver variability. The difference between two ob-
servers (J.P.K. and T.J.F.) who had no knowledge of each
other’s results were examined for the echocardiographic mor-
phometric measurements. The average difference between the
observers was 5 6 5.7%, and the correlation coefficient be-
tween the two sets of measurements was 0.94 (p , 0.0001).
Catheterization and balloon valvuloplasty. Balloon pulmo-
nary valvuloplasty was performed in all patients. The catheter-
ization data from both groups are shown in Table 3. The initial
and post balloon valvuloplasty RV to PA gradient and RV to
LV pressure ratio were similar in the two groups. There were
no significant differences between the two groups in the
hemodynamic variables examined.
Determinants of success of balloon pulmonary valvulo-
plasty. Balloon pulmonary valvuloplasty was successful in 9
(64%) of 14 patients with critical PS and in 18 (90%) of 20
patients with severe PS. Predictors of successful balloon pul-
monary valvuloplasty were examined in the patients with
critical PS (Table 3). The initial RV to PA pressure gradient
and initial RV to LV pressure ratio were significantly lower in
Figure 1. Scatterplot showing the Z values of the tricuspid valve (TVz)
(A), pulmonary valve (PVz) (B), main pulmonary artery (MPAz) (C),
right pulmonary artery (RPAz) (D) and left pulmonary artery (LPAz)
(E) in patients with critical PS at presentation and during the study
period. The shaded areas represent the mean value 6 2 SD of normal
control values. BSA 5 body surface area.
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patients with critical PS who had a successful balloon pulmo-
nary valvuloplasty. The total number of inflations and the
number of inflations with the maximal diameter balloon were
higher in patients who had failure of balloon pulmonary
valvuloplasty compared with those who had a successful pro-
cedure, presumably reflecting a sense of inadequate relief of
the obstruction in the catheterization laboratory. There were
no significant differences for the remainder of the hemody-
namic variables measured or for the various balloon dilation
techniques. Calendar year of procedure after 1988 was predic-
tive of success (p , 0.04) with only one failure occurring after
1988. There were no significant differences in the morphomet-
ric measurements between patients who had successful and
those who had unsuccessful balloon pulmonary valvuloplasty.
One patient who had a severely dysplastic PV, as defined by
Ettedgui et al. (20), underwent a successful balloon valvulo-
plasty. In two patients who had moderately dysplastic PVs,
balloon dilation was successful in one and unsuccessful in the
other. Because only two failures occurred in the group with
severe PS, and these were in cases in which an adequate
diameter balloon could not be advanced to the heart, no
predictors of successful balloon pulmonary valvuloplasty could
reliably be identified in this group of patients.
Outcomes. Among the five patients with critical PS in
whom balloon valvuloplasty had failed, three patients had
placement of a systemic to PA shunt and two had a surgical
valvotomy performed. One of the patients who underwent a
shunt procedure had a small RV and eventually had a Fontan
repair. Another patient who underwent a shunt procedure
subsequently underwent coil occlusion of his shunt, repeat
balloon pulmonary valvuloplasty and left PA stent placement,
and therefore required no further surgical treatment. One of
the patients had a surgical valvotomy and infundibular resec-
tion and had a complicated postoperative course with RV
failure. This patient eventually died, and this was the only
death in this group of patients. There were no major compli-
cations related to catheterization in this group of patients.
There was no restenosis after an initially successful balloon
valvuloplasty. One patient who initially had a shunt placed
required repeat balloon valvuloplasty 7 years later. In patients
with critical PS, the average RV to PA gradient at follow-up
was 15 6 10 mm Hg. All patients had pulmonary regurgitation
at follow-up, which was mild in 11 and moderate in three
patients. Of the three patients with moderate pulmonary
regurgitation, there was no evidence of RV volume overload
during follow-up in two patients. One patient had mild RV
enlargement by echocardiography.
Among patients with severe PS, there were two failures, and
both were related to the inability to advance a large enough
balloon to achieve adequate dilation. One case was an ex-
tremely premature infant who had avulsion of his inferior vena
cava. This patient had a Brock procedure and ligation of the
inferior vena cava and eventually died. This was the only death
in this group of patients. The other patient had partial relief of
his obstruction and underwent successful balloon pulmonary
valvuloplasty 11 months later. The only other major complica-
tion related to the catheterization in this group was in a patient
who had a small cerebral infarct, which was presumed to be
embolic. This patient had no long-term neurologic sequelae.
Restenosis after an initially successful balloon valvuloplasty
occurred in one of 18 patients. Two years after the procedure,
this patient had a RV to PA pressure gradient of 75 mm Hg
and underwent repeat balloon pulmonary valvuloplasty. In
patients with severe PS, the RV to PA gradient at follow-up
was 22 6 15 mm Hg. All patients had trivial to mild pulmonary
regurgitation at follow-up.










(n 5 5) p Value
Pre RV-PA gradient (mm Hg) 80 6 35 84 6 21 0.72 63 6 29 111 6 23 , 0.008
Post RV-PA gradient (mm Hg) 18 6 24 29 6 22 0.19 10 6 6 33 6 38 0.1
Pre RV/LV 1.3 6 0.5 1.2 6 0.2 0.2 1.1 6 0.4 1.8 6 0.3 , .001
Post RV/LV 0.7 6 0.3 0.6 6 0.2 0.07 0.6 6 0.2 0.9 6 0.3 0.09
Pre RVEDP (mm Hg) 8.1 6 2.8 8.7 6 3.2 0.56 7.4 6 2.8 9.2 6 2.6 0.27
Post RVEDP (mm Hg) 7.0 6 3.7 7.8 6 2.7 0.65 6.6 6 2.4 7.7 6 6.0 0.73
Pre mean RAP (mm Hg) 5.1 6 2.1 5.4 6 2.6 0.74 4.8 6 2.0 5.8 6 2.3 0.4
Pre RVEF (%) 62 6 17 56 6 6 0.21 60 6 15 64 6 21 0.67
Balloon/annulus ratio 1.4 6 .3 1.5 6 0.4 0.14 1.4 6 0.3 1.3 6 0.2 0.24
Single-/double-balloon ratio 8/6 6/14 0.08 5/4 3/2 0.42
Graduated/nongraduated ratio 11/3 12/8 0.16 7/2 4/1 0.49
Maximal inflation pressure (atm) 7.5 6 2.2 6.6 6 2.5 0.28 8.3 6 2.5 6.2 6 0.5 0.1
Total no. inflations 6.4 6 2.0 5.0 6 2.0 0.18 4.6 6 2.1 9.8 6 4.7 , 0.01
No. inflations with maximal
diameter balloon
3.7 6 2.7 3.7 6 1.3 0.93 2.6 6 1.7 5.8 6 3.0 , 0.02
Data are presented as mean value 6 SD or ratio. CPS 5 critical pulmonary stenosis; LV 5 left ventricle; PA 5 pulmonary artery; Post 5 after balloon pulmonary
valvuloplasty; Pre 5 before balloon pulmonary valvuloplasty; RAP 5 right atrial pressure; RV 5 right ventricle; RVEDP 5 right ventricular end-diastolic pressure;
RVEF 5 right ventricular ejection fraction; SPS 5 severe pulmonary stenosis.
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Discussion
This study demonstrates that the right heart structures
increase in size in patients with critical and severe PS after
balloon pulmonary valvuloplasty. In both groups, after ;3 to 4
years of follow-up, growth of the TV relative to somatic growth
was parallel to that of the normal population. The growth of
the PV annulus and PAs relative to somatic growth exceeded
that of normal control subjects (Fig. 1). The observation that
the growth rates of the PV annulus and PAs exceed that of the
normal population may be related to post-stenotic dilation or
to an increased RV stroke volume secondary to pulmonary
regurgitation. In patients with critical PS, the PAs became
dilated and significantly larger than the group with severe PS.
This may be related to the higher degree of pulmonary
regurgitation seen in these patients or to the presence of
surgical systemic to PA shunts in three patients. The increased
size of the PAs was not associated with any apparent clinical
problem in any of the study patients, but long-term follow-up
is warranted.
Previous studies. Previous studies have yielded varying
reports on the growth of the PV annulus. Although Fedderly et
al. (7) found that the Z values of the PV did not change
significantly after balloon valvuloplasty in patients with critical
PS, Tabatabaei et al. (14) found a significant increase. The Z
values demonstrated in this study were slightly larger than the
Z values reported in two previous studies (7,21). These small
differences may be explained by the varied techniques used.
The Z values of the PV annulus in these previous studies were
based on normative data derived from Hanseus et al. (22), in
which the measurement of the PV annulus was performed in
diastole. In the present study and in the patients used for
normative data, the PV annulus was measured in systole when
the annulus diameter is larger.
Distinguishing factors between critical and severe PS.
Patients with critical PS were distinguished from patients with
severe PS by several factors. These factors included a smaller
TV annulus diameter and RV volume and a higher degree of
tricuspid regurgitation in patients with critical PS. As expected,
all patients with critical PS demonstrated predominantly right
to left atrial shunting compared with predominantly left to
right shunting in patients with severe PS. Interestingly, there
were no significant differences between the two groups in the
hemodynamic variables measured including right atrial pres-
sure, RV end-diastolic pressure, RV to PA pressure gradient
and RV to LV pressure ratio. Unfortunately, left atrial pres-
sure was not routinely measured at catheterization, and this
would have allowed comparison of the right and left atrial
pressures. Speculatively, in patients with critical PS, decreased
pulmonary blood flow and subsequent decreased pulmonary
venous return may affect the relative compliance of the right
and left atria. Together with the higher degree of tricuspid
regurgitation, smaller TV and RV, this may contribute to the
differences in the degree of right to left atrial level shunting,
and thus to differences in clinical presentation.
Balloon pulmonary valvuloplasty. The overall success rate
of balloon pulmonary valvuloplasty for this study was 79%,
which is comparable to other studies (7,9–14,21). Restenosis
after successful balloon pulmonary valvuloplasty was rare and
occurred in ;3% of patients, none of whom had critical PS. In
patients with critical PS, a lower initial RV to PA pressure
gradient and RV to LV pressure ratio were associated with
successful balloon pulmonary valvuloplasty. A later year of
catheterization after 1988 was also shown to be associated with
success of the procedure. This may be related to operator
experience or to advances in techniques or technology. These
predictors of successful balloon pulmonary valvuloplasty are
comparable to other studies (7,21). Previous studies have
shown an association between morphometric variables and the
outcome of balloon pulmonary valvuloplasty, with larger PV
and TV diameters being associated with success of balloon
pulmonary valvuloplasty (7,11,21). None of the morphometric
variables measured in the present study were associated with
the success or failure of balloon pulmonary valvuloplasty. The
results of PV balloon dilation in this study, together with other
reports (7,9–14), support recommending balloon dilation as
the initial procedure in newborns and infants with critical and
severe PS.
Conclusions. This study demonstrates that growth of right
heart structures parallels or exceeds somatic growth after
balloon pulmonary valvuloplasty in patients with critical and
severe PS. The smaller right heart structures, higher degree of
tricuspid regurgitation and subsequent larger degree of right to
left atrial shunting in patients with critical PS compared with
infants with severe PS may contribute to differences in clinical
presentation.
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